Testing Pregnancy Tissue: What Karyotyping Reveals
SaveProducts-of-conception testing examines the chromosomes of miscarried tissue. About half of early losses carry a random chromosome error, and finding one usually signals bad luck rather than an inherited condition. Reproductive medicine bodies suggest testing most often after two or more miscarriages, while a normal result points the workup elsewhere.
Last updated: July 2026
What is pregnancy tissue testing?
Pregnancy tissue testing analyzes cells from the miscarried pregnancy, known as products of conception, to count and inspect the chromosomes. Two methods are common: a traditional karyotype, which photographs all 23 pairs, and chromosomal microarray, which reads the DNA in finer detail and is less likely to fail from non-growing samples 1Ref 1American College of Obstetricians and Gynecologists (2018).ACOG Practice Bulletin No. 200: Early Pregnancy Loss.About half of first-trimester losses result from chromosomal abnormalities, most arising randomly; describes karyotype and chromosomal microarray testing of products of conception.
The goal is to answer one question: did a chromosome error cause this loss? Around 50% of first-trimester miscarriages result from an extra or missing chromosome in the embryo, most of which arise by chance at conception 1Ref 1American College of Obstetricians and Gynecologists (2018).ACOG Practice Bulletin No. 200: Early Pregnancy Loss.About half of first-trimester losses result from chromosomal abnormalities, most arising randomly; describes karyotype and chromosomal microarray testing of products of conception. According to the American Society for Reproductive Medicine, testing the tissue can spare a couple unnecessary worry and guide whether further workup is warranted 2Ref 2Practice Committee of the American Society for Reproductive Medicine (2026).Recurrent pregnancy loss: a committee opinion.Products-of-conception testing is most useful after two or more losses; recurrent loss affects roughly 1-2% of couples; fewer than 5% of couples carry a structural chromosome rearrangement; evaluation includes uterine, clotting, and parental factors.
What does an aneuploidy result mean?
An aneuploidy result means the pregnancy had the wrong number of chromosomes, such as trisomy 16 or trisomy 21, and this is the single most common finding in early loss 1Ref 1American College of Obstetricians and Gynecologists (2018).ACOG Practice Bulletin No. 200: Early Pregnancy Loss.About half of first-trimester losses result from chromosomal abnormalities, most arising randomly; describes karyotype and chromosomal microarray testing of products of conception. Most of these errors happen randomly when the egg or sperm forms and are not passed down from either parent. For many people, that explanation is a relief because it points away from anything they did.
The chance of a chromosomally abnormal pregnancy rises with age: it is well under half for people in their early 20s and climbs steadily after 35, exceeding 50% in the early 40s 3Ref 3American College of Obstetricians and Gynecologists / American Society for Reproductive Medicine (2014).Female age-related fertility decline. Committee Opinion No. 589.The proportion of chromosomally abnormal pregnancies and miscarriage risk rises with maternal age, climbing markedly after the mid-30s and into the early 40s. Our page on why a miscarriage happened puts these numbers in context.
Who is offered products-of-conception testing?
Products-of-conception testing is most often offered after a second or third miscarriage, when a pattern raises the question of an underlying cause 2Ref 2Practice Committee of the American Society for Reproductive Medicine (2026).Recurrent pregnancy loss: a committee opinion.Products-of-conception testing is most useful after two or more losses; recurrent loss affects roughly 1-2% of couples; fewer than 5% of couples carry a structural chromosome rearrangement; evaluation includes uterine, clotting, and parental factors. Some clinics offer it after a first loss, especially if tissue is readily available or the pregnancy was further along. Insurance coverage and lab availability vary, so the offer is not universal.
The test needs a viable tissue sample, which is easier to obtain after a procedure than after a loss completed at home. When a result shows a normal count but the loss recurs, clinicians may broaden the workup. Our guide to how many miscarriages before testing explains the usual thresholds and what a full evaluation includes.
What does a normal (euploid) result mean?
A euploid result means the pregnancy had a normal chromosome count, so the loss was not explained by aneuploidy 1Ref 1American College of Obstetricians and Gynecologists (2018).ACOG Practice Bulletin No. 200: Early Pregnancy Loss.About half of first-trimester losses result from chromosomal abnormalities, most arising randomly; describes karyotype and chromosomal microarray testing of products of conception. That finding shifts attention toward other possible causes, such as uterine shape, blood-clotting or antiphospholipid issues, thyroid or hormonal factors, and, in some couples, a parental chromosome rearrangement 2Ref 2Practice Committee of the American Society for Reproductive Medicine (2026).Recurrent pregnancy loss: a committee opinion.Products-of-conception testing is most useful after two or more losses; recurrent loss affects roughly 1-2% of couples; fewer than 5% of couples carry a structural chromosome rearrangement; evaluation includes uterine, clotting, and parental factors.
A euploid loss in someone with repeated miscarriages is one trigger for a fuller recurrent-loss workup. That evaluation can include clotting-disorder testing and parental karyotyping, and it sometimes opens the door to embryo screening like PGT-A. According to ASRM, fewer than 5 in 100 couples with recurrent loss carry a structural chromosome change, but identifying one changes the plan 2Ref 2Practice Committee of the American Society for Reproductive Medicine (2026).Recurrent pregnancy loss: a committee opinion.Products-of-conception testing is most useful after two or more losses; recurrent loss affects roughly 1-2% of couples; fewer than 5% of couples carry a structural chromosome rearrangement; evaluation includes uterine, clotting, and parental factors.
When recurrent miscarriage needs a workup
Two or more clinical miscarriages, or a single loss with worrying features, is the usual point at which a structured evaluation makes sense 2Ref 2Practice Committee of the American Society for Reproductive Medicine (2026).Recurrent pregnancy loss: a committee opinion.Products-of-conception testing is most useful after two or more losses; recurrent loss affects roughly 1-2% of couples; fewer than 5% of couples carry a structural chromosome rearrangement; evaluation includes uterine, clotting, and parental factors. That workup pairs any tissue result with parental blood tests, a look at the uterine cavity, and screening for clotting and hormonal factors, building a fuller picture than tissue testing alone.
Recurrent loss affects roughly 1% to 2% of couples trying to conceive, and in more than half of thorough evaluations no single cause is found, which is frustrating but does not doom future pregnancies 2Ref 2Practice Committee of the American Society for Reproductive Medicine (2026).Recurrent pregnancy loss: a committee opinion.Products-of-conception testing is most useful after two or more losses; recurrent loss affects roughly 1-2% of couples; fewer than 5% of couples carry a structural chromosome rearrangement; evaluation includes uterine, clotting, and parental factors. A reproductive endocrinologist or gynecologist can interpret a tissue result alongside the rest. Gale can help you gather your records before that appointment.
Common questions
Related
Fertility & conception
Balanced Translocations: A Hidden Cause of LossFertility & conception
After a Chemical Pregnancy: When a Visit HelpsFertility & conception
Pregnant After Loss: Managing the Anxiety
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When to seek review after a loss
- —Two or more miscarriages is a reason to ask a clinician about products-of-conception and recurrent-loss testing
- —Heavy bleeding soaking a pad an hour, fever, or foul-smelling discharge is a reason to seek same-day urgent evaluation
- —Severe one-sided pelvic pain or fainting is a reason to seek emergency care for possible ectopic pregnancy
- —A euploid (normal) tissue result after repeated losses is a reason to arrange a fuller recurrent-loss workup
- —Ongoing grief, anxiety, or low mood after a loss is a reason to reach out to a clinician or counselor for support
This article is general health education, not medical advice. Whether tissue testing is right for you, and how to read a result, depends on your history and should be decided with a gynecologist or reproductive endocrinologist.
References
- 1.American College of Obstetricians and Gynecologists (2018). ACOG Practice Bulletin No. 200: Early Pregnancy Loss. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002899 ✓About half of first-trimester losses result from chromosomal abnormalities, most arising randomly; describes karyotype and chromosomal microarray testing of products of conception
- 2.Practice Committee of the American Society for Reproductive Medicine (2026). Recurrent pregnancy loss: a committee opinion. Fertility and Sterility. doi:10.1016/j.fertnstert.2026.03.001 ✓Products-of-conception testing is most useful after two or more losses; recurrent loss affects roughly 1-2% of couples; fewer than 5% of couples carry a structural chromosome rearrangement; evaluation includes uterine, clotting, and parental factors
- 3.American College of Obstetricians and Gynecologists / American Society for Reproductive Medicine (2014). Female age-related fertility decline. Committee Opinion No. 589. Obstetrics & Gynecology. doi:10.1097/01.AOG.0000444440.96486.61 ✓The proportion of chromosomally abnormal pregnancies and miscarriage risk rises with maternal age, climbing markedly after the mid-30s and into the early 40s
3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy